Menu
 
Research menu
Jump to menu

Publications:  Dr Orli Thau Zuchman

Thau-Zuchman O, Ingram R, Harvey GG, Cooke T, Palmas F, Pallier PN, Brook J, Priestley JV et al.(2020). A single injection of docosahexaenoic acid induces a pro-resolving lipid mediator profile in the injured tissue and a long-lasting reduction in neurological deficit after traumatic brain injury in mice. Journal of Neurotrauma vol. 37, (1) 66-79.
10.1089/neu.2019.6420
https://qmro.qmul.ac.uk/xmlui/handle/123456789/59204
Thau-Zuchman O, Gomes RN, Dyall SC, Davies M, Priestley JV, Groenendijk M, De Wilde MC, Tremoleda JL et al.(2019). Brain Phospholipid Precursors Administered Post-Injury Reduce Tissue Damage and Improve Neurological Outcome in Experimental Traumatic Brain Injury. Journal of Neurotrauma vol. 36, (1) 25-42.
10.1089/neu.2017.5579
https://qmro.qmul.ac.uk/xmlui/handle/123456789/45403
Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Vadivelu KC, Yip PK, Sosabowski J et al.(2016). In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [18F]GE-180 and effect of docosahexaenoic acid. European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-016-3391-8
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12308
Thau-Zuchman O, Pallier PN, Davies M, Groenendijk M, de Wilde MC, Tremoleda JL, Michael-Titus AT(2016). A specific multi-nutrient intervention, designed to enhance synapse formation and function, improves functional outcome following traumatic brain injury. BRAIN INJURY vol. 30, (5-6) 679-679.
Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Trigg W, Sosabowski J, Mather SJ et al. (2015). IN VIVO IMAGING OF NEUROINFLAMMATION IN NEUROTRAUMA PRECLINICAL MODELS: POTENTIAL FOR CLINICAL TRANSLATION. SHOCK. vol. 44, 24-25.
Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Trigg W, Sosabowski J, Mather SJ et al.(2015). T-14: IN VIVO IMAGING OF NEUROINFLAMMATION IN NEUROTRAUMA PRECLINICAL MODELS: POTENTIAL FOR CLINICAL TRANSLATION. Shock vol. 44 Suppl 2, 24-25.
10.1097/01.shk.0000472079.77136.27
Thau-Zuchman O(2015). Docosahexaenoic acid and traumatic brain injury. Lipid Technology vol. 27, (3) 63-66.
10.1002/lite.201500008
Thau-Zuchman O, Shohami E, Alexandrovich AG, Leker RR(2012). Combination of vascular endothelial and fibroblast growth factor 2 for induction of neurogenesis and angiogenesis after traumatic brain injury. Journal of Molecular Neuroscience vol. 47, (1) 166-172.
10.1007/s12031-012-9706-8
Thau-Zuchman O, Shohami E, Alexandrovich AG, Leker RR(2012). Subacute treatment with vascular endothelial growth factor after traumatic brain injury increases angiogenesis and gliogenesis. Neuroscience vol. 202, 334-341.
10.1016/j.neuroscience.2011.11.071
Thau-Zuchman O, Shohami E, Alexandrovich AG, Trembovler V, Leker RR(2012). The anti-inflammatory drug carprofen improves long-term outcome and induces gliogenesis after traumatic brain injury. Journal of Neurotrauma vol. 29, (2) 375-384.
10.1089/neu.2010.1673
Thau-Zuchman O, Shohami E, Alexandrovich AG, Leker RR(2010). Vascular endothelial growth factor increases neurogenesis after traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism vol. 30, (5) 1008-1016.
10.1038/jcbfm.2009.271
Return to top